correction to: microrna-335-5p is a potential suppressor of ......2021/03/08 · mir-335 nc wt 0 20...
TRANSCRIPT
Sandoval‑Bórquez et al. Clin Epigenet (2021) 13:50 https://doi.org/10.1186/s13148‑021‑01036‑2
CORRECTION
Correction to: MicroRNA‑335‑5p is a potential suppressor of metastasis and invasion in gastric cancerAlejandra Sandoval‑Bórquez1,2,3, Iva Polakovicova1,3, Nicolás Carrasco‑Véliz1,3,4, Lorena Lobos‑González5,6, Ismael Riquelme2, Gonzalo Carrasco‑Avino1,7, Carolina Bizama3,8, Enrique Norero9,10, Gareth I. Owen1,3,11, Juan C. Roa1,2,3,8 and Alejandro H. Corvalán1,3,12*
© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://crea‑tivecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdo‑main/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Correction to: Clinical Epigenetics (2017) 9:114 https ://doi.org/10.1186/s1314 8-017-0413-8
Following publication of the original article [1], the authors identified an error in Fig. 2. The correct figure is given below (Fig. 2).
Open Access
The original article can be found online at https ://doi.org/10.1186/s1314 8‑017‑0413‑8.
*Correspondence: [email protected] Advanced Center for Chronic Diseases (ACCDiS), Pontificia Universidad Católica de Chile, Santiago, ChileFull list of author information is available at the end of the article
Page 2 of 3Sandoval‑Bórquez et al. Clin Epigenet (2021) 13:50
a
e
0 h
10 h
20 h
b
c
d
miR-335 mimic NC mimic WT
miR-335 inhibitor NC inhibitor WT
miR-335 mimic NC mimic WT
miR-335 mimic NC mimic WT
miR-335 inhibitor NC inhibitor WT
miR-335 NC WT0
20
40
60
80
100
120
140
160
180
inhibitor inhibitor
**
M
igra
ting
cel
ls (%
)
miR-335 NC WT0
20
40
60
80
100
120
mimicmimic
**
Mig
rati
ng c
ells
(%)
0 10 200
20
40
60
80
100miR-335 mimicNC mimicWT
*
Time (hours)
Wou
nd (%
)
miR-335 NC WT0
20
40
60
80
100
120
140
160
180
inhibitor inhibitor
**
Inva
ding
cel
ls (%
)
miR-335 NC WT0
20
40
60
80
100
120
mimicmimic
***
Inva
ding
cel
ls (%
)
Page 3 of 3Sandoval‑Bórquez et al. Clin Epigenet (2021) 13:50
Author details1 Advanced Center for Chronic Diseases (ACCDiS), Pontificia Universidad Católica de Chile, Santiago, Chile. 2 Laboratory of Molecular Pathology, Depart‑ment of Pathology, School of Medicine, BIOREN‑CEGIN, and Graduate Program in Applied Cell and Molecular Biology, Universidad de La Frontera, Temuco, Chile. 3 Center UC for Investigational in Oncology (CITO), Pontificia Universidad Católica de Chile, Santiago, Chile. 4 Instituto de Química, Faculty of Science, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile. 5 Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santiago, Chile. 6 Fundación Ciencia Y Vida, Parque Biotecnológico, Santiago, Chile. 7 Depart‑ment of Pathology, Faculty of Medicine, Hospital Clínico Universidad de Chile, Santiago, Chile. 8 Department of Pathology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. 9 Esophagogastric Surgery Unit, Hospital Dr. Sótero del Río, Santiago, Chile. 10 Digestive Surgery Depart‑ment, Pontificia Universidad Católica de Chile, Santiago, Chile. 11 Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile. 12 Department of Hematology‑Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Reference 1. Sandoval‑Bórquez A, Polakovicova I, Carrasco‑Véliz N, Lobos‑González
L, Riquelme I, Carrasco‑Avino G, Bizama C, Norero E, Owen GI, Roa JC, Corvalán AH. MicroRNA‑335‑5p is a potential suppressor of metastasis and invasion in gastric cancer. Clin Epigenet. 2017;9:114. https ://doi.org/10.1186/s1314 8‑017‑0413‑8.
Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in pub‑lished maps and institutional affiliations.
(See figure on previous page.)Fig. 2 Overexpression of miR‑335 inhibits cell migration and invasion. a, b Representative images of AGS cells transfected with NC/miR‑335 mimic or with NC/miR‑335 inhibitor in migration assay. c Representative images of AGS cells transfected with control NC/miR‑335 mimic in wound healing assay. d, e Representative images of AGS cells transfected with control NC/miR‑335 mimic or with NC/miR‑335 inhibitor in invasion assay. Results represent the means of three independent experiments; bars indicate SD. *p < 0.05, **p < 0.01, ***p < 0.001. WT, wild type